LAG3 and breast carcinoma: In addition, VISTA expression is not associated with the expression of PD-L1, TIGIT, TIM3, and LAG3 in breast cancer, indicating that multiple immune checkpoint proteins cooperate to inhibit anti-tumor immunity and that the combined targeting of these molecules may be synergistic.